Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam for reducing hydrostatic reduction time in childhood intussusception
IRCT138904264395N1Phase 3Completed
- Sponsor
- Vice chancellor for research, Babol University of Medical Sciences
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of midazolam in intussusception (2 arms), sponsored by Vice chancellor for research, Babol University of Medical Sciences. Primary endpoint: Time of hydrostatic reduction. Started Jul 2011; status: completed.
02
Drugs
midazolam
03
Conditions
intussusception
Beyond the preview
Go deeper on IRCT138904264395N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138904264395N1.